The political collapse of the Soviet Union in the 1990s seems to have spurred on the killer strain of tuberculosis that is now spreading around the world. A genetic analysis of the TB bacterium's family tree has linked its global expansion to major historical events over the past few hundred years.
“Living-dead” bacteria exist in limbo: biologically active but not proliferating. Buried in this zombie state, disease-causing bacteria could come back from the dead to re-infect patients. Researchers at EPFL have produced the first evidence of this strange phenomenon in tuberculosis, suggesting new avenues for treatment.
THE Network of People Living With Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) in Nigeria (NEPWHAN) has called on the Attorney-General of the Federation and Minister of Justice to appeal the November court judgment that voided the ban on Dr. Jeremiah Abalaka’s HIV vaccine claim.
Bill Gates believes that a vaccine and new intensive drugs to combat HIV should be available by 2030 and end most new cases of the virus that has killed millions in the past three decades.
Scientists at the International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi and JNU have discovered a new molecule that can help develop a novel malaria vaccine against Plasmodium falciparum, one of the species of the parasite that causes malaria in humans.
Dr. Matshidiso Moeti was appointed to the new WHO post that will put her at the forefront of an international effort to stop the spread of Ebola.
Another example that underlines the Davos spirit of “entrepreneurialism in the global public interest” is the Global Fund, which was conceived at the 2002 meeting as a partnership between governments, civil society and businesses to accelerate the end of Aids, tuberculosis and malaria. By 2012 the Global Fund had deployed about $23bn to support programmes in over 150 countries. It has become the main funding platform to fight these global diseases.
Tuberculosis (TB) and multi drug-resistant tuberculosis (MDR-TB) are currently experiencing a dangerous upsurge across Europe. It is a public health crisis that is receiving too little attention, write Giovanni Battista Migliori and Stefano Alberti.
Tuberculosis (TB) remains the leading cause of death in South Africa followed by influenza and pneumonia. But HIV has moved from being ranked sixth in 2012 to third in 2013.
Three different vaccines against HIV – all developed in Russia – are ready for trial, an HIV specialist for the Russian Health Ministry announced at a press conference held on World AIDS Day.